BICARA THERAPEUTICS INC. - COMMON STOCK

12.24

04-February-25 15:45:00

15 minutes delayed

Stocks

-0.06

-0.49%

Today's range

11.76 - 12.54

ISIN

N/A

Source

NASDAQ

Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results with Ficerafusp Alfa in Advanced Squamous Cancer of the Anal Canal at the 2025 ASCO Gastrointestinal Cancers Symposium

27 Jan 2025 07:00:15 By Nasdaq GlobeNewswire
Bicara Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

12 Nov 2024 06:30:49 By Nasdaq GlobeNewswire
Bicara Therapeutics to Present at the Stifel 2024 Healthcare Conference

11 Nov 2024 15:01:02 By Nasdaq GlobeNewswire
Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

16 Sep 2024 15:01:00 By Nasdaq GlobeNewswire

<<
<
1
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.